secretogranin
Selected indexed studies
- Secretogranin 2 binds LILRB4 resulting in immunosuppression. (Nat Immunol, 2025) [PMID:40707822]
- The chromogranin-secretogranin family. (N Engl J Med, 2003) [PMID:12646671]
- Secretogranin III: a diabetic retinopathy-selective angiogenic factor. (Cell Mol Life Sci, 2018) [PMID:28856381]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Secretogranin 2 binds LILRB4 resulting in immunosuppression. (2025) pubmed
- The chromogranin-secretogranin family. (2003) pubmed
- Secretogranin III: a diabetic retinopathy-selective angiogenic factor. (2018) pubmed
- Secretogranin III: a promising therapeutic target for intraocular neovascular lesions. (2025) pubmed
- The granin (chromogranin/secretogranin) family. (1991) pubmed
- Secretogranin II: molecular properties, regulation of biosynthesis and processing to the neuropeptide secretoneurin. (1995) pubmed
- Secretogranin III stringently regulates pathological but not physiological angiogenesis in oxygen-induced retinopathy. (2022) pubmed
- Secretogranin III: a bridge between core hormone aggregates and the secretory granule membrane. (2010) pubmed
- Investigation of the Expression and Regulation of SCG5 in the Context of the Chromogranin-Secretogranin Family in Malignant Tumors. (2024) pubmed
- Chromogranins A and B and secretogranin II: evolutionary and functional aspects. (2008) pubmed